Antifungal therapy – Page 18

Phaeohyphomycosis due to Nigrograna chromolaenae in a cardiac transplant patient

mycolabadmin

A 71-year-old heart transplant patient developed a slowly growing bump on his finger caused by a rare fungus called Nigrograna chromolaenae. Doctors initially tried common antifungal medications that didn’t work well, but the patient improved significantly when switched to posaconazole treatment. This is the first documented case of this particular fungus infecting a human, highlighting the importance of accurately identifying fungi to choose the right treatment.

Fungal peritonitis in a patient on peritoneal dialysis caused by Hyphopichia burtonii: A rare pathogen in human infection

mycolabadmin

A woman undergoing peritoneal dialysis for kidney failure developed a serious fungal infection caused by a rare yeast called Hyphopichia burtonii. Doctors identified the infection using advanced laboratory techniques and treated her with antifungal medication after removing her dialysis catheter. She recovered well and switched to a different type of dialysis. This case highlights how unusual fungi can cause infections in patients with weakened kidney function.

Life-threatening airway stenosis due to Scedosporium infection during nontuberculous mycobacteria treatment: A case report

mycolabadmin

A 73-year-old woman with arthritis treated with immunosuppressive drugs and a lung infection developed a life-threatening narrowing of her airway caused by a rare fungal infection called Scedosporium apiospermum. Doctors used a combination of emergency measures including a breathing support machine, insertion of a special tube to keep the airway open, and strong antifungal medication to treat the infection. After six months of treatment, the fungal infection was completely gone and the special airway tube was successfully removed, allowing normal healing.

A Case of Pulmonary Infection Due to Magnusiomyces capitatus in a Non-Immunocompromised Patient with Cerebral Palsy

mycolabadmin

A young man with cerebral palsy developed a rare lung infection caused by Magnusiomyces capitatus, a fungus that usually only affects people with weakened immune systems. Doctors diagnosed the infection by analyzing fluid from his lungs and identified the fungus using advanced laboratory techniques. The patient improved after being treated with an antifungal medication called voriconazole. This case highlights that this rare fungal infection can occur in otherwise healthy people, especially those with conditions affecting their ability to clear lung secretions.

Safety and Efficacy of a 48-Month Efinaconazole 10% Solution Treatment/Maintenance Regimen: 24-Month Daily Use Followed by 24-Month Intermittent Use

mycolabadmin

Researchers studied a 4-year treatment plan for toenail fungal infections using efinaconazole, an antifungal solution applied daily for 2 years, then 2-3 times weekly for another 2 years. The treatment was safe and effective, with all patients who achieved a cure maintaining it through the maintenance phase, and even some non-cured patients improving further. The study included many elderly patients, showing the treatment is safe across all age groups and could help prevent infection relapse.

Candidemia due to Candida lambica in a neutropenic oncology patient: A rare case report

mycolabadmin

A 56-year-old cancer patient developed a rare blood infection caused by an unusual yeast called Candida lambica while receiving chemotherapy. Despite taking antifungal medication for prevention, the patient developed a serious fever and low white blood cell count. Doctors identified the infection through genetic testing and treated it with a different antifungal drug called voriconazole, which successfully cleared the infection.

Gastrointestinal and Intra-Abdominal Mucormycosis in Non-Haematological Patients—A Comprehensive Review

mycolabadmin

This review examines a serious but rare fungal infection called mucormycosis that affects the stomach and intestines. The infection most commonly occurs in patients with diabetes, those who have received organ transplants, or those in intensive care units. Diagnosis can be difficult because symptoms are non-specific, but prompt treatment with antifungal medications and surgery when possible significantly improves survival rates. Early recognition and rapid diagnosis are critical for patients to have the best outcomes.

Clinical Outcomes of Micafungin for Invasive Fungal Infections in the Obese and Nonobese

mycolabadmin

This study examined whether obese patients treated with the antifungal drug micafungin for serious fungal infections had different outcomes compared to non-obese patients. Researchers reviewed 378 patient cases and found that both groups had similar success rates of about 50%, suggesting that the standard dose of micafungin works equally well in obese and non-obese patients. These findings suggest that doctors do not need to prescribe higher doses of micafungin specifically for obese patients, though more research is needed to fully understand how obesity affects antifungal treatment.

First report of Stemphylium lycopersici keratitis, a complex corneal infection case

mycolabadmin

A 66-year-old man developed a severe corneal infection from a stone chip injury that didn’t improve with standard antibiotics. Doctors discovered the infection was caused by a rare plant fungus called Stemphylium lycopersici, combined with a herpes virus. Using advanced genetic testing (mNGS) to identify the exact pathogens, they prescribed targeted antifungal and antiviral medications along with a corneal transplant, successfully healing the infection and preserving his vision.

The refractory nailbed ulceration caused by Candida parapsilosis after nail extraction

mycolabadmin

An 82-year-old woman developed a stubborn ulcer on her toenail bed after having the nail surgically removed to treat an infected nail fold. Testing revealed the ulcer was caused by a yeast called Candida parapsilosis, which typically causes infections after physical trauma or injury to the skin. Treatment with an antifungal medication called fluconazole successfully healed the ulcer over three months. This is the first reported case of this specific type of infection following nail removal and highlights the importance of properly identifying the cause of chronic nail infections.

Research Topic: Antifungal therapy